Finzati - Logo
ALKS logo

Alkermes plc

ALKS • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHLY FAVORABLE PROFILEExcellentConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$8.11B
Growth
9.5%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Stable or improving margins · 16.4%Positive revenue growth · 5.3%Positive free cash flow · 2.92Consistent free cash flow · 4/5Reasonable earnings multiple · 19.07
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$8.11B
52W Range25.17 - 55.67
Beta0.29
Gross Margin86.69%
Oper. Margin17.21%
Profit Margin16.37%
Debt/Eq0.04
Current Ratio3.55
Quick Ratio3.19
Revenue 5Y9.50%

Investment DNA

How strong this company looks for long-term investors

85
out of 100
Business Quality
Margins, moat, returns
82/100
Financial Strength
Debt, cash, stability
95/100
Growth Potential
Revenue and expansion
83/100
Price Attractiveness
Cheap or expensive today
80/100
Why this score▼
Stable or improving margins · 16.4%Positive revenue growth · 5.3%Positive free cash flow · 2.92Consistent free cash flow · 4/5Reasonable earnings multiple · 19.07Manageable debt level · 0.04

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-07-30
Low
$43.00
Mean
$55.86
Median
$56.00
High
$65.00

Company Overview

IPO: 7/16/1991
Industry: Biotechnology
P/B i: 2.53
Debt / Equity i: 0.04
Operating Margin: 17.21%
Net Margin: 16.37%
ROE i: -
ROIC: -

Financial Health

Score19 / 20
Debt / Equity: 0.04
Current Ratio: 3.55
Quick Ratio: 3.19
Status: Strong

Insider Transactions

Recent executive and insider activity

Gaffin David Joseph
Transaction: 07/06/2026
SELL
Change
-2,034
Price
$54.03
Filing
07/06/2026
Type
SELL
Hopkinson Craig C.
Transaction: 07/01/2026
SELL
Change
-5,000
Price
$19.34
Filing
07/01/2026
Type
SELL
Hopkinson Craig C.
Transaction: 07/01/2026
SELL
Change
-700
Price
$52.13
Filing
07/01/2026
Type
SELL